4.5 Article

A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-β Protein 42 Levels

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

2016 Alzheimer's disease facts and figures

Alzheimers & Dementia (2016)

Review Clinical Neurology

The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy

Patrick L. McGeer et al.

ACTA NEUROPATHOLOGICA (2013)

Article Multidisciplinary Sciences

A mutation in APP protects against Alzheimer's disease and age-related cognitive decline

Thorlakur Jonsson et al.

NATURE (2012)

Article Clinical Neurology

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study

Felix Bermejo-Pareja et al.

BMC NEUROLOGY (2010)

Article Geriatrics & Gerontology

Beta amyloid and hyperphosphorylated tau deposits in the pancreas in type 2 diabetes

Judith Miklossy et al.

NEUROBIOLOGY OF AGING (2010)

Article Clinical Neurology

Protective effects of NSAIDs on the development of Alzheimer disease

Steven C. Vlad et al.

NEUROLOGY (2008)

Article Biochemistry & Molecular Biology

Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Aβ42 production

T Kukar et al.

NATURE MEDICINE (2005)

Article Medicine, General & Internal

Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease

BA in 't Veld et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)